State Street Corp Better Therapeutics, Inc. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.34 - $1.23 $4,556 - $16,482
13,400 Added 29.65%
58,600 $21,000
Q2 2022

Aug 15, 2022
BUY
$0.91 - $2.34 $41,132 - $105,768
45,200 New
45,200 $71,000
Q1 2022

May 16, 2022
SELL
$1.98 - $5.01 $26,387 - $66,768
-13,327 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.58 - $17.14 $61,037 - $228,424
13,327 New
13,327 $62,000

Others Institutions Holding BTTX

# of Institutions
1
Shares Held
3K
Call Options Held
0
Put Options Held
0
View Full List

About Better Therapeutics, Inc.

BTTX Quotes by TradingView
  • Ticker BTTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,743,000
  • Description
  • Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...
More about BTTX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email